Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

FDA issues new guidelines to treat opioid use disorder

The U.S. FDA issued new draft guidelines to treat opioid use disorders that include using medication-assisted treatment drugs.

Thumbnail

70% of Americans feel opioid misuse is a statewide problem

The CDC reported more than 50 percent of drug overdose deaths involve an opioid. And in the past two decades, opioid-related overdose deaths has increased by more than five times.

Thumbnail

Democrats to force vote against short-term health plans

In response to the Trump administration’s decision to expand short-term health plans, Senate Democrats will try to force a vote to block the rule, the Associated Press reported.

Thumbnail

New York’s single-payer health system could work—with tax increases

As the debate over a possible single-payer health system heats up, at least one study has shown such a model is viable in New York—with a few catches.

Thumbnail

Healthcare remains a leader in job growth

Healthcare was once again a leader among the number of jobs added to the economy in July, according to the most recent jobs report from the U.S. Bureau of Labor Statistics.

Thumbnail

Cities file suit claiming Trump administration is sabotaging ACA

Chicago, Baltimore, Cincinnati and Columbus, Ohio, filed a joint lawsuit accusing the Trump administration of actively undermining the Affordable Care Act.

Thumbnail

CMS finalizes 2019 hospital payments, scraps controversial inpatient reimbursement rule

CMS finalized a rule for inpatient and long-term care hospital payments, tossing out a controversial reimbursement plan with it.

Thumbnail

California official throws wrench in planned CVS-Aetna merger

The planned merger of CVS Health and Aetna hit a snag this week after California Insurance Commissioner Dave Jones urged the U.S. Department of Justice to block the $69 billion deal.

Around the web

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Trimed Popup
Trimed Popup